(Q28195954)

https://api.crossref.org/works/10.1046/J.1471-0528.2003.02096.X

1 January 2024

0 references

1 reference

6

Gérard Breart

1 reference

Europe PubMed Central

PubMed publication ID

12742332

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742332

1 January 2024

author name string

Damien Subtil

1

0 references

Patrice Goeusse

2

0 references

Francis Puech

3

0 references

Pierre Lequien

4

0 references

Serge Biausque

5

0 references

Serge Uzan

7

0 references

Pierre Marquis

8

0 references

Dominique Parmentier

9

0 references

Alain Churlet

10

0 references

Essai Régional Aspirine Mère-Enfant (ERASME) Collaborative Group

11

1 reference

Europe PubMed Central

PubMed publication ID

12742332

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742332

full work available at URL

1 January 2024

language of work or name

English

0 references

publication date

May 2003

0 references

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1471-0528.2003.02096.x

1 reference

https://api.crossref.org/works/10.1046/J.1471-0528.2003.02096.X

https://obgyn.onlinelibrary.wiley.com/doi/pdf/10.1046/j.1471-0528.2003.02096.x

1 January 2024

1 reference

https://api.crossref.org/works/10.1046/J.1471-0528.2003.02096.X

BJOG: an International Journal of Obstetrics and Gynaecology

1 January 2024

published in

0 references

volume

110

0 references

issue

5

0 references

page(s)

475-84

0 references

cites work

Risk factors for preeclampsia

2

1 reference

https://api.crossref.org/works/10.1046/J.1471-0528.2003.02096.X

National High Blood Pressure Education Program Working Group Report on High Blood Pressure in Pregnancy

1 January 2024

3

1 reference

https://api.crossref.org/works/10.1046/J.1471-0528.2003.02096.X

Risk factors and clinical manifestations of pre-eclampsia

1 January 2024

4

1 reference

https://api.crossref.org/works/10.1046/J.1471-0528.2003.02096.X

Underlying disorders associated with severe early-onset preeclampsia

1 January 2024

5

1 reference

https://api.crossref.org/works/10.1046/J.1471-0528.2003.02096.X

Prevention of pre-eclampsia by early antiplatelet therapy

1 January 2024

6

1 reference

https://api.crossref.org/works/10.1046/J.1471-0528.2003.02096.X

The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies

1 January 2024

7

1 reference

https://api.crossref.org/works/10.1046/J.1471-0528.2003.02096.X

A Meta-analysis of Low-Dose Aspirin for the Prevention of Pregnancy-Induced Hypertensive Disease

1 January 2024

8

1 reference

https://api.crossref.org/works/10.1046/J.1471-0528.2003.02096.X

A randomised trial of low dose aspirin for primiparae in pregnancy

1 January 2024

11

1 reference

https://api.crossref.org/works/10.1046/J.1471-0528.2003.02096.X

Low-Dose Aspirin to Prevent Preeclampsia in Women at High Risk

1 January 2024

12

1 reference

https://api.crossref.org/works/10.1046/J.1471-0528.2003.02096.X

Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review

1 January 2024

14

1 reference

https://api.crossref.org/works/10.1046/J.1471-0528.2003.02096.X

1 January 2024

15

1 reference

https://api.crossref.org/works/10.1046/J.1471-0528.2003.02096.X

A meta-analysis of low dose aspirin for the prevention of intrauterine growth retardation

1 January 2024

16

1 reference

https://api.crossref.org/works/10.1046/J.1471-0528.2003.02096.X

Low-dose aspirin: lack of association with an increase in abruptio placentae or perinatal mortality

1 January 2024

17

1 reference

https://api.crossref.org/works/10.1046/J.1471-0528.2003.02096.X

Effect of aspirin in pregnant women is dependent on increase in bleeding time.

1 January 2024

21

1 reference

https://api.crossref.org/works/10.1046/J.1471-0528.2003.02096.X

Bias in meta-analysis detected by a simple, graphical test

1 January 2024

22

1 reference

https://api.crossref.org/works/10.1046/J.1471-0528.2003.02096.X

North of England evidence based guideline development project: guideline on the use of aspirin as secondary prophylaxis for vascular disease in primary care. North of England Aspirin Guideline Development Group

1 January 2024

24

1 reference

https://api.crossref.org/works/10.1046/J.1471-0528.2003.02096.X

Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group

1 January 2024

25

1 reference

https://api.crossref.org/works/10.1046/J.1471-0528.2003.02096.X

Pre-eclampsia in second pregnancy

1 January 2024

27

1 reference

https://api.crossref.org/works/10.1046/J.1471-0528.2003.02096.X

Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study

1 January 2024

28

1 reference

https://api.crossref.org/works/10.1046/J.1471-0528.2003.02096.X

A prospective management study of slow-release aspirin in the palliation of uteroplacental insufficiency predicted by uterine artery Doppler at 20 weeks

1 January 2024

29

1 reference

https://api.crossref.org/works/10.1046/J.1471-0528.2003.02096.X

1 January 2024

Identifiers

10.1016/S1470-0328(03)02996-3

0 references

1 reference

National Center for Biotechnology Information

PubMed publication ID

12742332